LIFETECH SCI Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend

Bulletin Express

Aug 12

LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters.

The agenda includes: 1. Approval of the Group’s unaudited interim results for the six months ended 30 June 2026 and authorisation to publish the results on the websites of Hong Kong Exchanges and Clearing Limited and the Company. 2. Consideration of an interim dividend distribution. 3. Potential closure of the Company’s register of members. 4. Discussion of any additional business items.

The meeting notice was authorised by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on 12 August 2026. The Board currently comprises three executive directors—Mr. Xie Yuehui, Ms. Wu Liping and Mr. Fang Yu—and three independent non-executive directors—Mr. Zhou Luming, Ms. Chen Dongxia and Mr. Jiang Feng.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1130346916"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130346916\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130346916?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 19:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130346916","market":"us","top_or_hot":-1,"title":"LIFETECH SCI Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend","media":"Bulletin Express","content":"<p>LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters.</p>\n<p>The agenda includes:\n1. Approval of the Group’s unaudited interim results for the six months ended 30 June 2026 and authorisation to publish the results on the websites of Hong Kong Exchanges and Clearing Limited and the Company.  \n2. Consideration of an interim dividend distribution.  \n3. Potential closure of the Company’s register of members.  \n4. Discussion of any additional business items.</p>\n<p>The meeting notice was authorised by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on 12 August 2026. The Board currently comprises three executive directors—Mr. Xie Yuehui, Ms. Wu Liping and Mr. Fang Yu—and three independent non-executive directors—Mr. Zhou Luming, Ms. Chen Dongxia and Mr. Jiang Feng.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIFETECH SCI Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIFETECH SCI Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-12 19:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters.</p>\n<p>The agenda includes:\n1. Approval of the Group’s unaudited interim results for the six months ended 30 June 2026 and authorisation to publish the results on the websites of Hong Kong Exchanges and Clearing Limited and the Company.  \n2. Consideration of an interim dividend distribution.  \n3. Potential closure of the Company’s register of members.  \n4. Discussion of any additional business items.</p>\n<p>The meeting notice was authorised by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on 12 August 2026. The Board currently comprises three executive directors—Mr. Xie Yuehui, Ms. Wu Liping and Mr. Fang Yu—and three independent non-executive directors—Mr. Zhou Luming, Ms. Chen Dongxia and Mr. Jiang Feng.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01302","symbol_name":"先健科技","start_time":0,"source_url":"","article_id":"1130346916","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130346916","pubTimestamp":1786535184,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters. The agenda includes: 1. Approval of the Group’s unaudited interim...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01302":"先健科技"},"translate_title":"LIFETECH SCI 计划于 2026 年 8 月 28 日召开董事会会议，批准 2026 年上半年业绩并评估中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01302":1},"content_text":"LifeTech Scientific Corporation (LIFETECH SCI) has convened a board meeting for 28 August 2026 to address several key matters.\nThe agenda includes:\n1. Approval of the Group’s unaudited interim results for the six months ended 30 June 2026 and authorisation to publish the results on the websites of Hong Kong Exchanges and Clearing Limited and the Company.  \n2. Consideration of an interim dividend distribution.  \n3. Potential closure of the Company’s register of members.  \n4. Discussion of any additional business items.\nThe meeting notice was authorised by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on 12 August 2026. The Board currently comprises three executive directors—Mr. Xie Yuehui, Ms. Wu Liping and Mr. Fang Yu—and three independent non-executive directors—Mr. Zhou Luming, Ms. Chen Dongxia and Mr. Jiang Feng.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}